Health and Healthcare

AstraZeneca : AZN

All AstraZeneca Articles

218 Articles

Jon C. Ogg | Apr 27, 2012 at 9:15 AM EDT

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the…

Jon C. Ogg | Apr 23, 2012 at 2:54 PM EDT

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to…

Paul Ausick | Apr 23, 2012 at 7:59 AM EDT

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer.…

Paul Ausick | Mar 27, 2012 at 9:41 AM EDT

Targacept Gets Mixed Results on Drug Trials (TRGT, AZN)

Development stage drug maker Targacept Inc. (NASDAQ: TRGT) is having its troubles these days. Earlier this month the company said…

Douglas A. McIntyre | Mar 27, 2012 at 6:38 AM EDT

Media Digest (3/27/2012) Reuters, WSJ, NYT, FT, Bloomberg

Increasing numbers of mutual funds have performances tied to huge investments in Apple (NASDAQ: AAPL). (Reuters) Tim Cook, Apple’s CEO,…

Paul Ausick | Mar 26, 2012 at 2:29 PM EDT

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

We noted earlier today that AstraZeneca plc (NYSE: AZN) had lost a patent ruling and that the company’s anti-pyschotic drug…

Paul Ausick | Mar 26, 2012 at 7:36 AM EDT

AstraZeneca Loses Patent Fight (AZN)

Late last Friday, drug maker AstraZeneca PLC (NYSE: AZN) lost its court fight to prevent a generic version of its…

Paul Ausick | Mar 20, 2012 at 12:44 PM EDT

Targacept Slammed on Failed Drug Trial (TRGT, AZN)

Drug developer Targacept Inc. (NASDAQ: TRGT) and partner AstraZeneca plc (NYSE: AZN) today announced that they will not file for…

Paul Ausick | Feb 7, 2012 at 4:06 PM EST

24/7 Wall St. Closing Bell (SIRI, IBM, AZN, URBN, ZOLT, YUM, MT, BP, KO, EMR, LPX, MNI, CSTR, SPF, NSU, BPAX)

US equity markets opened lower this morning, but after the first hour or so of trading, the three major indexes…

Jon C. Ogg | Feb 7, 2012 at 8:12 AM EST

Top Analyst Upgrades & Downgrades (AON, AZN, CSCO, DLR, DRIV, HSIC, IBM, PBY, CRM, SNH, SSW, SIRI, SOHU, SXL, THO, URBN, ZOLT)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…

Douglas A. McIntyre | Feb 2, 2012 at 6:47 AM EST

What’s Important in the Financial World (2/2/2012) AstraZeneca Layoffs, Sony Losses

Today is Facebook Day. It will be remembered that way as long as there are IPOs. The Facebook public offering has…

Paul Ausick | Jan 9, 2012 at 7:15 AM EST

AstraZeneca Re-Confirms Forecast Following Goof (AZN)

Drug maker AstraZeneca PLC (NYSE: AZN) has issued a press release re-confirming the company’s December forecast following a load of…

Douglas A. McIntyre | Jan 6, 2012 at 6:39 AM EST

Short Sellers Help Push Dendreon Higher

Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that…

Jon C. Ogg | Jan 5, 2012 at 8:21 AM EST

Top Analyst Upgrades & Downgrades (AZN, BLK, BRCM, CEG, ED, EBAY, ERIC, EXC, GOOG, NFLX, NOK, PSUN, SOL, SAP, SNY, TRN, UPS, VVUS, VMW)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms…

Paul Ausick | Dec 20, 2011 at 12:10 PM EST

AstraZeneca Drug Fails Trial, Really Hurts Partner (AZN, TRGT)

Pharmaceutical company AstraZeneca plc (NYSE: AZN) is looking for another big winner to replace its Nexium heartburn drug and its…

1 … 10 11 12 13 14 15

AstraZeneca : AZN

All AstraZeneca Articles

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Targacept Gets Mixed Results on Drug Trials (TRGT, AZN)

Media Digest (3/27/2012) Reuters, WSJ, NYT, FT, Bloomberg

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

AstraZeneca Loses Patent Fight (AZN)

Targacept Slammed on Failed Drug Trial (TRGT, AZN)

24/7 Wall St. Closing Bell (SIRI, IBM, AZN, URBN, ZOLT, YUM, MT, BP, KO, EMR, LPX, MNI, CSTR, SPF, NSU, BPAX)

Top Analyst Upgrades & Downgrades (AON, AZN, CSCO, DLR, DRIV, HSIC, IBM, PBY, CRM, SNH, SSW, SIRI, SOHU, SXL, THO, URBN, ZOLT)

What’s Important in the Financial World (2/2/2012) AstraZeneca Layoffs, Sony Losses

AstraZeneca Re-Confirms Forecast Following Goof (AZN)

Short Sellers Help Push Dendreon Higher

Top Analyst Upgrades & Downgrades (AZN, BLK, BRCM, CEG, ED, EBAY, ERIC, EXC, GOOG, NFLX, NOK, PSUN, SOL, SAP, SNY, TRN, UPS, VVUS, VMW)

AstraZeneca Drug Fails Trial, Really Hurts Partner (AZN, TRGT)

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

AstraZeneca : AZN

All AstraZeneca Articles

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Targacept Gets Mixed Results on Drug Trials (TRGT, AZN)

Media Digest (3/27/2012) Reuters, WSJ, NYT, FT, Bloomberg

Teva Launches Generic Seroquel on First Day of Patent Loss (TEVA, AZN)

AstraZeneca Loses Patent Fight (AZN)

Targacept Slammed on Failed Drug Trial (TRGT, AZN)

24/7 Wall St. Closing Bell (SIRI, IBM, AZN, URBN, ZOLT, YUM, MT, BP, KO, EMR, LPX, MNI, CSTR, SPF, NSU, BPAX)

Top Analyst Upgrades & Downgrades (AON, AZN, CSCO, DLR, DRIV, HSIC, IBM, PBY, CRM, SNH, SSW, SIRI, SOHU, SXL, THO, URBN, ZOLT)

What’s Important in the Financial World (2/2/2012) AstraZeneca Layoffs, Sony Losses

AstraZeneca Re-Confirms Forecast Following Goof (AZN)

Short Sellers Help Push Dendreon Higher

Top Analyst Upgrades & Downgrades (AZN, BLK, BRCM, CEG, ED, EBAY, ERIC, EXC, GOOG, NFLX, NOK, PSUN, SOL, SAP, SNY, TRN, UPS, VVUS, VMW)

AstraZeneca Drug Fails Trial, Really Hurts Partner (AZN, TRGT)

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not